Page last updated: 2024-09-04

ukrain and Cancer of Pancreas

ukrain has been researched along with Cancer of Pancreas in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campani, D; Chiriva-Internati, M; Cobos, E; Colombo, G; Costa, F; Dalle-Donne, I; Funel, N; Gagliano, N; Milzani, A; Pettinari, L; Sala, A; Taddeo, A1
Barajon, I; Clerici, M; Colombo, G; Dalle-Donne, I; Gagliano, N; Martinelli, C; Milzani, A; Pettinari, L; Portinaro, N; Volpari, T1
Hodysh, Y; Nowicky, W; Prokopchuk, O; Susak, Y; Tkachenko, O; Zemskov, S; Zemskov, V1
Ernst, E; Schmidt, K1
Hodysh, YY; Procopchuk, OL; Susak, YM; Zemskov, SV; Zemskov, VS; Zemskova, MV1
Beger, HG; Cammerer, G; Gansauge, F; Gansauge, S; Leder, G; Muehling, B; Pressmar, J; Ramadani, M; Stecker, K1

Reviews

1 review(s) available for ukrain and Cancer of Pancreas

ArticleYear
Ukrain - a new cancer cure? A systematic review of randomised clinical trials.
    BMC cancer, 2005, Jul-01, Volume: 5

    Topics: Alkaloids; Antineoplastic Agents; Berberine Alkaloids; Breast Neoplasms; Chelidonium; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Data Interpretation, Statistical; Databases, Factual; Humans; Neoplasms; Pancreatic Neoplasms; Phenanthridines; Plant Extracts; Plants, Medicinal; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Bladder Neoplasms

2005

Trials

2 trial(s) available for ukrain and Cancer of Pancreas

ArticleYear
Ukrain (NSC-631570) in the treatment of pancreas cancer.
    Drugs under experimental and clinical research, 2000, Volume: 26, Issue:5-6

    Topics: Adult; Aged; Alkaloids; Antineoplastic Agents, Phytogenic; Berberine Alkaloids; Body Weight; Female; Humans; Karnofsky Performance Status; Male; Middle Aged; Pain Measurement; Pancreatic Neoplasms; Phenanthridines; Pilot Projects; Survival Analysis

2000
NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial.
    Langenbeck's archives of surgery, 2002, Volume: 386, Issue:8

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alkaloids; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Berberine Alkaloids; Deoxycytidine; Drug Therapy, Combination; Female; Gemcitabine; Humans; Injections, Intravenous; Male; Middle Aged; Pancreatic Neoplasms; Phenanthridines; Prospective Studies; Survival Analysis; Treatment Outcome

2002

Other Studies

3 other study(ies) available for ukrain and Cancer of Pancreas

ArticleYear
Ukrain affects pancreas cancer cell phenotype in vitro by targeting MMP-9 and intra-/extracellular SPARC expression.
    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2010, Volume: 10, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Berberine Alkaloids; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Osteonectin; Pancreatic Neoplasms; Phenanthridines; RNA, Messenger; Tumor Microenvironment; Up-Regulation

2010
Pancreatic cancer cells retain the epithelial-related phenotype and modify mitotic spindle microtubules after the administration of ukrain in vitro.
    Anti-cancer drugs, 2012, Volume: 23, Issue:9

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Berberine Alkaloids; beta Catenin; Cadherins; Carcinoma, Pancreatic Ductal; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Humans; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Microtubules; Mitosis; Mitotic Index; Pancreatic Neoplasms; Phenanthridines; Phenotype; Spindle Apparatus; Time Factors

2012
Efficacy of ukrain in the treatment of pancreatic cancer.
    Langenbeck's archives of surgery, 2002, Volume: 387, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alkaloids; Antineoplastic Agents; Berberine Alkaloids; Female; Humans; Male; Middle Aged; Palliative Care; Pancreatic Neoplasms; Phenanthridines; Pilot Projects; Prognosis; Quality of Life

2002